TradingView
AlenCiken
Jul 13, 2018 9:17 PM
CLBS granted regenerative medicine advanced therapy by FDA
Long
NASDAQ:CLBS
240
Description
⋅
Jul 13, 2018 9:17 PM
Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina
caladrius.com/press-release/caladrius-receives-fda-regenerative-medicine-advanced-therapy-designation-for-cd34-cell-therapy-for-treating-refractory-angina/
Trend Analysis
Chart Patterns
Technical Indicators
More